Zhen J Wang Selected Research

Therapeutics

1/2022	Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer.
12/2020	Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional imaging techniques.
9/2020	Protocol Optimization for Renal Mass Detection and Characterization.
1/2020	Estimation of Fractional Extracellular Space at CT for Predicting Chemotherapy Response and Survival in Pancreatic Ductal Adenocarcinoma.
11/2017	Comparative Effectiveness of Tumor Response Assessment Methods: Standard of Care Versus Computer-Assisted Response Evaluation.
1/2017	Hyperpolarized 13C Spectroscopic Evaluation of Oxidative Stress in a Rodent Model of Steatohepatitis.
10/2015	Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor.
9/2015	Real-time measurement of hyperpolarized lactate production and efflux as a biomarker of tumor aggressiveness in an MR compatible 3D cell culture bioreactor.
2/2015	Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhen J Wang Research Topics

Disease

21	Neoplasms (Cancer) 12/2022 - 01/2004
8	Renal Cell Carcinoma (Grawitz Tumor) 09/2020 - 03/2010
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2013
4	Adenocarcinoma 01/2020 - 06/2013
3	Fibrosis (Cirrhosis) 05/2017 - 06/2009
2	Liver Cirrhosis (Hepatic Cirrhosis) 05/2017 - 01/2015
2	Necrosis 01/2017 - 03/2012
2	Hypoxia (Hypoxemia) 03/2012 - 11/2008
1	Metabolic Diseases (Metabolic Disease) 12/2022
1	Kidney Diseases (Kidney Disease) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 12/2020
1	Polyps 10/2020
1	Pyelonephritis 11/2018
1	Diabetes Mellitus 01/2018
1	Insulin Resistance 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2017
1	Inflammation (Inflammations) 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Heart Failure 01/2017
1	Disease Progression 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016
1	End Stage Liver Disease 05/2016
1	Carcinogenesis 10/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 02/2015
1	Ureteral Obstruction 05/2010
1	Transitional Cell Carcinoma 12/2009
1	Hemoperitoneum 09/2009
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2009
1	Suppuration 09/2009
1	Ascites 09/2009
1	Cysts 09/2008
1	Ovarian Neoplasms (Ovarian Cancer) 05/2008
1	Biliary Atresia 05/2002

Drug/Important Bio-Agent (IBA)

8	Lactic Acid (Lactate)FDA LinkGeneric 11/2021 - 01/2013
6	Pyruvic Acid (Pyruvate)IBA 01/2022 - 10/2015
4	Contrast MediaIBA 01/2022 - 01/2004
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2018 - 12/2009
3	Biomarkers (Surrogate Marker)IBA 10/2015 - 08/2013
3	GadoliniumIBA 01/2015 - 01/2004
2	Biological ProductsIBA 09/2018 - 01/2013
2	Furosemide (Lasix)FDA LinkGeneric 03/2012 - 05/2010
1	EnzymesIBA 12/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Hormones (Hormone)IBA 11/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	IodineIBA 10/2020
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2018
1	Lactate Dehydrogenase 5IBA 09/2018
1	Isoflurophate (DFP)FDA Link 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Sunitinib (Sutent)FDA Link 11/2017
1	Protons (Proton)IBA 09/2017
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 05/2017
1	Drinking WaterIBA 05/2017
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	folfirinoxIBA 10/2016
1	NAD (NADH)IBA 10/2015
1	Niacinamide (Nicotinamide)FDA LinkGeneric 10/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2015
1	Nicotinamide PhosphoribosyltransferaseIBA 10/2015
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2015
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2015
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 08/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	Sulfhydryl Compounds (Thiols)IBA 06/2013
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2013
1	AmidesIBA 06/2013
1	mercury orangeIBA 06/2013
1	Glucose (Dextrose)FDA LinkGeneric 06/2013
1	Glutathione (Reduced Glutathione)IBA 06/2013
1	MucinsIBA 09/2009
1	CreatinineIBA 09/2009
1	gadodiamide (Omniscan)FDA Link 06/2009
1	Oxygen (Dioxygen)IBA 11/2008
1	antineoplaston A10 (A 10)IBA 09/2008
1	ferric oxide (iron oxide)IBA 05/2008
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2008

Therapy/Procedure

9	Therapeutics 01/2022 - 02/2015
5	Bioreactors (Bioreactor) 03/2016 - 01/2013
3	Neoadjuvant Therapy 12/2020 - 10/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 10/2016
1	Aftercare (After-Treatment) 11/2018
1	Kidney Transplantation 05/2017
1	Radiotherapy 10/2016
1	Liver Transplantation 05/2016
1	Intraperitoneal Injections 01/2015
1	Radiofrequency Ablation 03/2010
1	Hepatic Portoenterostomy 05/2002